Chernajovsky Y - Search Results

1

A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation.

La M, Cao TV, Cerchiaro G, Chilton K, Hirabayashi J, Kasai K, Oliani SM, Chernajovsky Y, Perretti M. La M, et al. Among authors: chernajovsky y. Am J Pathol. 2003 Oct;163(4):1505-15. doi: 10.1016/s0002-9440(10)63507-9. Am J Pathol. 2003. PMID: 14507657 Free PMC article.

2

Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics.

Vessillier S, Adams G, Montero-Melendez T, Jones R, Seed M, Perretti M, Chernajovsky Y. Vessillier S, et al. Among authors: chernajovsky y. Ann Rheum Dis. 2012 Jan;71(1):143-9. doi: 10.1136/annrheumdis-2011-200100. Epub 2011 Oct 13. Ann Rheum Dis. 2012. PMID: 21998117

3

Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis.

Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y. Rabinovich GA, et al. Among authors: chernajovsky y. J Exp Med. 1999 Aug 2;190(3):385-98. doi: 10.1084/jem.190.3.385. J Exp Med. 1999. PMID: 10430627 Free PMC article.

4

Targeting cytokines to inflammation sites.

Adams G, Vessillier S, Dreja H, Chernajovsky Y. Adams G, et al. Among authors: chernajovsky y. Nat Biotechnol. 2003 Nov;21(11):1314-20. doi: 10.1038/nbt888. Epub 2003 Oct 5. Nat Biotechnol. 2003. PMID: 14528315

5

A comparative study of matrix metalloproteinase and aggrecanase mediated release of latent cytokines at arthritic joints.

Mullen L, Adams G, Foster J, Vessillier S, Köster M, Hauser H, Layward L, Gould D, Chernajovsky Y. Mullen L, et al. Among authors: chernajovsky y. Ann Rheum Dis. 2014 Sep;73(9):1728-36. doi: 10.1136/annrheumdis-2013-203513. Epub 2013 Jun 27. Ann Rheum Dis. 2014. PMID: 23813971

6

Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope protein.

Annenkov AE, Daly GM, Chernajovsky Y. Annenkov AE, et al. Among authors: chernajovsky y. J Gene Med. 2002 Mar-Apr;4(2):133-40. doi: 10.1002/jgm.258. J Gene Med. 2002. PMID: 11933214

7

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide.

Wythe SE, DiCara D, Taher TE, Finucane CM, Jones R, Bombardieri M, Man YK, Nissim A, Mather SJ, Chernajovsky Y, Pitzalis C. Wythe SE, et al. Among authors: chernajovsky y. Ann Rheum Dis. 2013 Jan;72(1):129-35. doi: 10.1136/annrheumdis-2012-201457. Epub 2012 Jul 27. Ann Rheum Dis. 2013. PMID: 22843486 Free PMC article.

8

Generation of an efficiently secreted, cell penetrating NF-κB inhibitor.

Koutsokeras A, Purkayastha N, Rigby A, Subang MC, Sclanders M, Vessillier S, Mullen L, Chernajovsky Y, Gould D. Koutsokeras A, et al. Among authors: chernajovsky y. FASEB J. 2014 Jan;28(1):373-81. doi: 10.1096/fj.13-236570. Epub 2013 Sep 26. FASEB J. 2014. PMID: 24072781

9

Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.

Isomäki P, Panesar M, Annenkov A, Clark JM, Foxwell BM, Chernajovsky Y, Cope AP. Isomäki P, et al. Among authors: chernajovsky y. J Immunol. 2001 May 1;166(9):5495-507. doi: 10.4049/jimmunol.166.9.5495. J Immunol. 2001. PMID: 11313388

10

Novel delivery methods to achieve immunomodulation.

Gould DJ, Chernajovsky Y. Gould DJ, et al. Among authors: chernajovsky y. Curr Opin Pharmacol. 2007 Aug;7(4):445-50. doi: 10.1016/j.coph.2007.05.002. Epub 2007 Jul 3. Curr Opin Pharmacol. 2007. PMID: 17611159 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page